Advertisement

Clinical Relevance of Proliferation Rates in Renal Cell Carcinoma

  • W. de Riese
  • E. P. Allhoff
  • C. G. Stief
  • R. Schlick
  • P. Anton
  • U. Jonas
Conference paper

Abstract

Flemming (1882) and Waldeyer (1888) were the first to describe the histomorphological conception of cell division, mitosis and cell proliferation in human malignancies [5]. In different malignant tumors, pathologists found a correlation between mitosis rate determined in histological specimens and the clinical course of patients with malignancies. Mitosis, however, plays only a small part in the active cell cycle and is therefore only an indirect parameter of the proliferative pattern of the tissue. A long time passed before direct detection of tumor-specific proliferation rates (PRs) was possible. Through autoradiographic studies using the thymidine incorporation assay direct measurement of the portion of DNA synthesizing cells became available. In 1979, H.M. Rabes and his coworkers presented a clinical report of PR in renal cell carcinoma (RCC) using this technique [10]. They found a correlation between PR and recurrence rate in a series of ten patients. The main disadvantages of the thymidine incorporation technique are (a) extracorporal organ perfusion (ex vivo) after tumor nephrectomy and (b) radioactivity; therefore, it is not a practicable technique for routine diagnosis.

Keywords

Renal Cell Carcinoma Renal Cell Carcinoma Patient Normal Renal Tissue Tumor Nephrectomy Human Nuclear Antigen 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Cordell JL, Falini B, Erber NW, et al. (1984) Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal antialkaline phosphatase (APAAP complexes). J Histochem Cytochem 32: 219–229PubMedCrossRefGoogle Scholar
  2. 2.
    Gerdes J, Schwab U, Lemke H, Stein H (1983) Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 31: 13–20PubMedCrossRefGoogle Scholar
  3. 3.
    Gerdes J, Dallenbach F, Lennert K (1984) Growth fractions in malignant non-Hodgkin’s lymphomas (NHL) as determined in situ with the monoclonal antibody Ki-67. Hemat Oncol 2: 365–371Google Scholar
  4. 4.
    Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H (1984) Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 133: 1710–1715PubMedGoogle Scholar
  5. 5.
    Girod C (1986) Die Entwicklung der Kenntnisse von der Zelle. In: Toeliner R (Hrsg) Illustrierte Geschichte der Medizin. Rabe, Stuttgart, S 1884–1893Google Scholar
  6. 6.
    Hanauske AR, Von Hoff DD (1985) Clinical correlations with the human tumor cloning assay. Cancer Invest 3: 541–551PubMedCrossRefGoogle Scholar
  7. 7.
    Hermanek P, Sobin LH (1987) Classification of urological tumors. In: Hermanek P, Sobin LH (eds) TNM classification of malignant tumors, 4th edn. Springer, Berlin Heidelberg New York Tokyo, pp 137–139Google Scholar
  8. 8.
    De Kernion JB (1986) Renal Tumors. In: Walsh PC, Gittes RF, Permutter AD, Stamey TA (eds) Campbell’s Urology, 5th edn., vol 2. Saunders, Philadelphia, pp 1297–1342Google Scholar
  9. 9.
    Lelle RJ, Heidenreich W, Stauch G, Gerdes J (1987) The correlation of growth fractions with histologic grading and lymph node status in human mammary carcinoma. Cancer 59: 83–88PubMedCrossRefGoogle Scholar
  10. 10.
    Rabes HM, Carl P, Meister P, Rattenhuber U (1979) Analysis of proliferative compartments in renal adenocarcinoma: Cancer 44: 799–804PubMedGoogle Scholar
  11. 11.
    Schorn A, Marberger M (1984) Long-term survival of untreated bilateral renal cell carcinoma with supradiaphragmatic vena caval thrombus. J Urol 131: 108–109PubMedGoogle Scholar
  12. 12.
    Von Hoff DD (1987) In-vitro predictive testing. Int J Cell Cloning 5: 179–190CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1992

Authors and Affiliations

  • W. de Riese
    • 1
  • E. P. Allhoff
    • 1
  • C. G. Stief
    • 1
  • R. Schlick
    • 1
  • P. Anton
    • 1
  • U. Jonas
    • 1
  1. 1.Medizinische Hochschule HannoverUrologische KlinikHannover 61Germany

Personalised recommendations